Nvidia and Eli Lilly Team Up: Does It Signal Broader Real-World Adoption for AI?
NVIDIA and Eli Lilly announced a $1B, five-year investment to build a joint research lab, leveraging Nvidia’s latest Vera Rubin AI platform. Does this partnership open a new long-term growth lane for Nvidia beyond hyperscalers? Can AI materially improve drug discovery efficiency and margins for pharma leaders like Eli Lilly?
+ Follow
+6